#NewAllyAseBio | "AseBio represents the meeting place for all the companies in the biotech sector at a national level"
Meet JORI & ARMENGOL, our new ally. We talked to María Sanjuanbenito, ejecutiva de Cuentas.
AseBio. What does your company's work bring to the table and what is its strength?
María Sanjuanbenito. The value of Jori Armengol is the know-how in the sector, because in addition to understand your technical vocabulary, which has cost us, we have already solved problems of the same nature (coverage for clinical trials, experience in the daily problems with companies in the pharmaceutical sector...).
We help the Technical-Financial and HR departments to cover their risks and, in the event of a claim, to minimize its impact on the company.
AseBio. What is AseBio for you?
María Sanjuanbenito. AseBio represents the meeting place for all the companies in the biotech sector at a national level, and to know the current market proposals. In addition, it allows us to anticipate the needs that the rest of the associates may have.
AseBio. When did you first hear about AseBio?
María Sanjuanbenito. A year and a half ago, through a colleague who works in the industry and has participated in several of your events.
AseBio. What is the biggest challenge facing the biotech sector (or your company)?
María Sanjuanbenito. The biggest challenge in the biotech sector is to create solutions that we did not think could exist.